Rani P Reddi, Begum Jasmina
Professor, Department of Obstetrics & Gynecology, Mahatama Gandhi Medical College and Research Institute , Pillaiyarkuppam, Puducherry, India .
Associate Professor, Department of Obstetrics & Gynecology, Mahatama Gandhi Medical College and Research Institute , Pillaiyarkuppam, Puducherry, India .
J Clin Diagn Res. 2016 Apr;10(4):QE01-4. doi: 10.7860/JCDR/2016/17588.7689. Epub 2016 Apr 1.
Gestational Diabetes Mellitus (GDM) is defined as any glucose intolerance with the onset or first recognition during pregnancy. This definition helps for diagnosis of unrecognized pre-existing Diabetes also. Hyperglycemia in pregnancy is associated with adverse maternal and prenatal outcome. It is important to screen, diagnose and treat Hyperglycemia in pregnancy to prevent an adverse outcome. There is no international consensus regarding timing of screening method and the optimal cut-off points for diagnosis and intervention of GDM. DIPSI recommends non-fasting Oral Glucose Tolerance Test (OGTT) with 75g of glucose with a cut-off of ≥ 140 mg/dl after 2-hours, whereas WHO (1999) recommends a fasting OGTT after 75g glucose with a cut-off plasma glucose of ≥ 140 mg/dl after 2-hour. The recommendations by ADA/IADPSG for screening women at risk of diabetes is as follows, for first and subsequent trimester at 24-28 weeks a criteria of diagnosis of GDM is made by 75 g OGTT and fasting 5.1mmol/l, 1 hour 10.0mmol/l, 2 hour 8.5mmol/l by universal glucose tolerance testing. Critics of these criteria state that it causes over diagnosis of GDM and unnecessary interventions, the controversy however continues. The ACOG still prefer a 2 step procedure, GCT with 50g glucose non-fasting if value > 7.8mmol/l followed by 3-hour OGTT for confirmation of diagnosis. In conclusion based on Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study as mild degree of dysglycemia are associated with adverse outcome and high prevalence of Type II DM to have international consensus It recommends IADPSG criteria, though controversy exists. The IADPSG criteria is the only outcome based criteria, it has the ability to diagnose and treat GDM earlier, thereby reducing the fetal and maternal complications associated with GDM. This one step method has an advantage of simplicity in execution, more patient friendly, accurate in diagnosis and close to international consensus. Keeping in the mind the diversity and variability of Indian population, judging international criteria may not be conclusive, thus further comparative studies are required on different diagnostic criteria in relation to adverse pregnancy outcomes.
妊娠期糖尿病(GDM)被定义为孕期首次出现或首次被识别的任何葡萄糖不耐受情况。该定义也有助于诊断未被识别的孕前糖尿病。孕期高血糖与不良的母体和围产儿结局相关。筛查、诊断和治疗孕期高血糖以预防不良结局很重要。关于GDM筛查方法的时机以及诊断和干预的最佳切点,目前尚无国际共识。糖尿病妊娠研究组(DIPSI)推荐采用非空腹口服葡萄糖耐量试验(OGTT),口服75克葡萄糖,2小时后血糖切点≥140毫克/分升,而世界卫生组织(1999年)推荐空腹口服75克葡萄糖后的OGTT,2小时后血浆葡萄糖切点≥140毫克/分升。美国糖尿病协会/国际糖尿病妊娠研究组(ADA/IADPSG)对糖尿病风险女性的筛查建议如下,在孕早期和孕晚期24 - 28周时,通过75克OGTT进行GDM诊断,采用通用葡萄糖耐量试验,空腹血糖5.1毫摩尔/升、1小时血糖10.0毫摩尔/升、2小时血糖8.5毫摩尔/升。这些标准的批评者称其会导致GDM过度诊断和不必要的干预,然而争议仍在继续。美国妇产科医师学会(ACOG)仍倾向于两步法,非空腹口服50克葡萄糖进行葡萄糖筛查试验(GCT),如果值>7.8毫摩尔/升,则随后进行3小时OGTT以确诊。总之,基于高血糖与不良妊娠结局(HAPO)研究,由于轻度血糖异常与不良结局以及2型糖尿病的高患病率相关,为达成国际共识,推荐国际糖尿病妊娠研究组(IADPSG)标准,尽管存在争议。IADPSG标准是唯一基于结局的标准,它能够更早地诊断和治疗GDM,从而减少与GDM相关的胎儿和母体并发症。这种一步法在实施上具有简单、对患者更友好、诊断准确且接近国际共识的优点。考虑到印度人群的多样性和变异性,评判国际标准可能并不具有决定性意义,因此需要针对不同诊断标准与不良妊娠结局开展进一步的比较研究。